SPONSOR
Hefei TG ImmunoPharma Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Advanced or Metastatic Solid TumorsOvarian CancerMelanomaTriple Negative Breast CancerColorectal Cancer
Hefei TG ImmunoPharma Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Advanced or Metastatic Solid Tumors, Ovarian Cancer, Melanoma, Triple Negative Breast Cancer.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hefei TG ImmunoPharma Co., Ltd.
How many clinical trials has Hefei TG ImmunoPharma Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Hefei TG ImmunoPharma Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Advanced or Metastatic Solid Tumors, Ovarian Cancer, Melanoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hefei TG ImmunoPharma Co., Ltd. research focus on?
Hefei TG ImmunoPharma Co., Ltd. clinical trials span Advanced or Metastatic Solid Tumors, Ovarian Cancer, Melanoma, Triple Negative Breast Cancer, Colorectal Cancer. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hefei TG ImmunoPharma Co., Ltd. clinical trial?
To participate in a Hefei TG ImmunoPharma Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hefei TG ImmunoPharma Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Hefei TG ImmunoPharma Co., Ltd.
NCT06374173 Phase 1
Recruiting
A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors
Advanced or Metastatic Solid Tumors
NCT05746897 Phase 1
Recruiting
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Ovarian Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology